These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20565444)

  • 1. Antimanic and mood-stabilizing effect of memantine as an augmenting agent in treatment-resistant bipolar disorder.
    Koukopoulos A; Reginaldi D; Serra G; Koukopoulos A; Sani G; Serra G
    Bipolar Disord; 2010 May; 12(3):348-9. PubMed ID: 20565444
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimanic and long-lasting mood stabilizing effect of memantine in bipolar I mood disorder: two case reports.
    Serra G; De Chiara L; Koukopoulos A; Serra G
    J Clin Psychopharmacol; 2013 Oct; 33(5):715-7. PubMed ID: 24002206
    [No Abstract]   [Full Text] [Related]  

  • 3. Memantine-related psychotic symptoms in a patient with bipolar disorder.
    Canan F; Ataoglu A
    J Clin Psychiatry; 2010 Jul; 71(7):957. PubMed ID: 20667296
    [No Abstract]   [Full Text] [Related]  

  • 4. The sustained mood-stabilizing effect of memantine in the management of treatment resistant bipolar disorders: findings from a 12-month naturalistic trial.
    Koukopoulos A; Serra G; Koukopoulos AE; Reginaldi D; Serra G
    J Affect Disord; 2012 Jan; 136(1-2):163-166. PubMed ID: 22030128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of add-on low-dose memantine on cytokine levels in bipolar II depression: a 12-week double-blind, randomized controlled trial.
    Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang YS; Wang LJ; Lee IH; Wang TY; Yeh TL; Yang YK; Hong JS; Lu RB
    J Clin Psychopharmacol; 2014 Jun; 34(3):337-43. PubMed ID: 24717258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Memantine in the treatment and prophylaxis of bipolar type II mood disorder and co-morbid eating disorder: a case report.
    De Chiara L; Serra G; Koukopoulos AE; Koukopoulos A; Serra G
    Riv Psichiatr; 2014; 49(4):192-4. PubMed ID: 25174697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Memantine efficacy and safety in patients with acute mania associated with bipolar I disorder: a pilot evaluation.
    Keck PE; Hsu HA; Papadakis K; Russo J
    Clin Neuropharmacol; 2009; 32(4):199-204. PubMed ID: 19620854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memantine reduces mania-like symptoms in animal models.
    Gao Y; Payne RS; Schurr A; Hougland T; Lord J; Herman L; Lei Z; Banerjee P; El-Mallakh RS
    Psychiatry Res; 2011 Aug; 188(3):366-71. PubMed ID: 21269711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memantine in the treatment and prophylaxis of bipolar II disorder and comorbid fibromyalgia: a case report.
    Serra G; DE Chiara L; Koukopoulos AE; Koukopoulos A; Serra G; Kahn DA
    J Psychiatr Pract; 2014 May; 20(3):232-6. PubMed ID: 24847998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently.
    Macfadden W; Alphs L; Haskins JT; Turner N; Turkoz I; Bossie C; Kujawa M; Mahmoud R
    Bipolar Disord; 2009 Dec; 11(8):827-39. PubMed ID: 19922552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
    Lee JH; Dunner DL
    Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study.
    Vieta E; Goikolea JM; Corbella B; Benabarre A; Reinares M; Martínez G; Fernández A; Colom F; Martínez-Arán A; Torrent C;
    J Clin Psychiatry; 2001 Oct; 62(10):818-25. PubMed ID: 11816872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of bipolar depression with carbamazepine: results of an open study.
    Dilsaver SC; Swann SC; Chen YW; Shoaib A; Joe B; Krajewski KJ; Gruber N; Tsai Y
    Biol Psychiatry; 1996 Nov; 40(9):935-7. PubMed ID: 8896785
    [No Abstract]   [Full Text] [Related]  

  • 14. Memantine may acutely improve cognition and have a mood stabilizing effect in treatment-resistant bipolar disorder.
    Teng CT; Demetrio FN
    Braz J Psychiatry; 2006 Sep; 28(3):252-4. PubMed ID: 17063225
    [No Abstract]   [Full Text] [Related]  

  • 15. Add-on memantine to valproate treatment increased HDL-C in bipolar II disorder.
    Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang YS; Wang LJ; Lee IH; Yeh TL; Yang YK; Lu RB; Hong JS
    J Psychiatr Res; 2013 Oct; 47(10):1343-8. PubMed ID: 23870798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compliance with maintenance treatment in bipolar disorder.
    Keck PE; McElroy SL; Strakowski SM; Bourne ML; West SA
    Psychopharmacol Bull; 1997; 33(1):87-91. PubMed ID: 9133756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up.
    Mazza M; Mandelli L; Di Nicola M; Harnic D; Catalano V; Tedeschi D; Martinotti G; Colombo R; Bria P; Serretti A; Janiri L
    J Affect Disord; 2009 May; 115(1-2):27-35. PubMed ID: 18845344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression.
    Zarate CA; Quiroz JA; Singh JB; Denicoff KD; De Jesus G; Luckenbaugh DA; Charney DS; Manji HK
    Biol Psychiatry; 2005 Feb; 57(4):430-2. PubMed ID: 15705360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memantine in the treatment of dementia.
    Maggiore C; Locatelli L; Grandi FC; Pizzolato G;
    Neuroepidemiology; 2007; 28(2):118-9. PubMed ID: 17409774
    [No Abstract]   [Full Text] [Related]  

  • 20. Mania in the Nordic countries: patients and treatment in the acute phase of the EMBLEM study.
    Larsen JK; Porsdal V; Aarre TF; Koponen HJ; Aarnio J; Kleivenes OK;
    Nord J Psychiatry; 2009; 63(4):285-91. PubMed ID: 19140076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.